REFERENCES
- Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994; 83: 1251–1257, [PUBMED], [INFOTRIEVE], [CSA]
- van Ommen C H, Heijboer H, Buller H R, Hirasing R A, Heijmans H S, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139: 676–681, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Andrew M, Monagle P T, Brooker L. Thromboemblic Complications During Infancy and Childhood. B.C Decker, London 2000
- Massicotte M P, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133: 770–776, [PUBMED], [INFOTRIEVE], [CSA]
- Nowak-Gottl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost 2001; 86: 464–474, [PUBMED], [INFOTRIEVE], [CSA]
- Bertina R M. Genetic approach to thrombophilia. Thromb Haemost 2001; 86: 92–103, [PUBMED], [INFOTRIEVE], [CSA]
- Ariens R A, de Lange M, Snieder H, Boothby M, Spector T D, Grant P J. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet 2002; 359: 667–671, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Briet E, van der Meer F J, Rosendaal F R, Houwing-Duistermaat J J, van Houwelingen H C. Family history and inherited thrombophilia. Br J Haematol 1994; 87: 348–352, [PUBMED], [INFOTRIEVE], [CSA]
- Ruud E, Holmstrom H, Natvig S, Wesenberg F. Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer: a prospective study. Med Pediatr Oncol 2002; 38: 405–410, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. New Engl J Med 2001; 344: 1222–1231, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Martinelli I, Mannucci P M, De Sa V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998; 92: 2353–2358, [PUBMED], [INFOTRIEVE], [CSA]
- Rees D C, Cox M, Clegg J B. World distribution of factor V Leiden. Lancet 1995; 346: 1133–1134, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Sa V, Martinelli I, Mannucci P M, et al. The risk of recurrent deep venous thrombosis among heterozygous, carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999; 341: 801–806, [CROSSREF], [CSA]
- Nowak-Gottl U, Koch H G, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. [comment]. Br J Haematol. 1996; 92: 992–998, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nowak-Gottl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood. 1999; 93: 1595–1599, [PUBMED], [INFOTRIEVE], [CSA]
- Schobess R, Junker R, Auberger K, Munchow N, Burdach S, Nowak-Gottl U, Factor V. G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis-evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation. Eur J Pediatr 1999; 158: S105–S108, [PUBMED], [INFOTRIEVE], [CSA]
- Schambeck C M, Schwender S, Haubitz I, Geisen U E, Grossman R E, Keller F. Selective screening for the factor V leiden mutation: is it advisable prior to the prescription of oral contraceptives?. Thromb Haemost 1997; 78: 1480–1483, [PUBMED], [INFOTRIEVE], [CSA]
- Nowak-Gootl U, Junker R, Hartmeier M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation. 1999; 100: 742–748, [CSA]
- Nowakk-Gottl U, Debus O, Findeisen M, et al. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics 1997; 99: ell, [CSA]
- Nakajima K, Hata Y. Intraindividual variation in lipoprotein(a) levels and factors related to these changes. J Atheroscler Thromb 1996; 2: 96–106, [PUBMED], [INFOTRIEVE], [CSA]
- Refsum H, Wesenberg F, Ueland P M. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methrotrexate. Cancer Res 1991; 51: 828–835, [PUBMED], [INFOTRIEVE], [CSA]
- Vilaseca M A, Moyano D, Ferrer I, Artuch R. Total homocysteine in pediatric patients. Clin Chem 1997; 43: 690–692, [PUBMED], [INFOTRIEVE], [CSA]
- Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 1257–1265, [PUBMED], [INFOTRIEVE], [CSA]
- Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G. Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study. BMJ 2001; 322: 1024–1025, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]